Compounds > ursodeoxycholic acid
Page last updated: 2024-08-23

ursodeoxycholic acid and Cancer of Prostate

ursodeoxycholic acid has been researched along with Cancer of Prostate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnold, LA; Bikle, DD; Bogart, JW; Cook, JM; Preston, JV; Sanchez, LM; Silvaggi, NR; Teske, KA; Yu, OB1
Habe, K; Higashiyama, A; Mizutani, H; Omoto, Y; Yamanaka, K; Yokoyama, T1
Choi, YH; Im, EO; Jin, Y; Kim, ND; Suh, H; Yoo, YH1
Barbara, L; Cicognani, C; Malavolti, M; Morselli-Labate, AM; Sama, C1
Aoki, T; Araki, H; Date, S; Fujito, A; Imada, N; Imaide, Y; Iwamoto, N; Kamoi, K; Kitamori, T; Kitamura, K; Kojima, M; Mikami, K; Miki, T; Miyashita, H; Nakao, M; Ohe, H; Saitoh, M; Takada, H; Tanaka, S; Uchida, M; Ukimura, O1

Other Studies

5 other study(ies) available for ursodeoxycholic acid and Cancer of Prostate

ArticleYear
Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
    European journal of medicinal chemistry, 2016, Feb-15, Volume: 109

    Topics: Calcitriol; Cell Line, Tumor; Cholesterol; Glucuronates; Humans; Lithocholic Acid; Male; Prostatic Neoplasms; Receptors, Calcitriol; Transcription, Genetic; Vitamin D; Vitamin D3 24-Hydroxylase

2016
Flutamide-induced photoleukomelanoderma.
    The Journal of dermatology, 2016, Volume: 43, Issue:9

    Topics: Administration, Cutaneous; Aged; Androgen Antagonists; Benzimidazoles; Biopsy; Biphenyl Compounds; Bisoprolol; Clopidogrel; Drug Eruptions; Eicosapentaenoic Acid; Ezetimibe; Flutamide; Glucocorticoids; Humans; Male; Patch Tests; Photosensitivity Disorders; Prostatic Neoplasms; Skin Pigmentation; Sunlight; Tetrazoles; Ticlopidine; Ursodeoxycholic Acid; Withholding Treatment

2016
Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells.
    Cancer letters, 2003, Sep-25, Volume: 199, Issue:2

    Topics: Apoptosis; Blotting, Western; Caspases; Cell Cycle; Cell Cycle Proteins; Chenodeoxycholic Acid; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA-Binding Proteins; DNA, Neoplasm; Dose-Response Relationship, Drug; E2F Transcription Factors; E2F1 Transcription Factor; Humans; Indoles; Luciferases; Male; Phosphorylation; Poly(ADP-ribose) Polymerases; Precipitin Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Retinoblastoma Protein; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ursodeoxycholic Acid

2003
Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:11

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Flutamide; Humans; Leuprolide; Male; Prostatic Neoplasms; Ursodeoxycholic Acid

1996
Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary study.
    International journal of urology : official journal of the Japanese Urological Association, 2002, Volume: 9, Issue:1

    Topics: Aged; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Flutamide; Humans; Liver Diseases; Male; Prostatic Neoplasms; Retrospective Studies; Ursodeoxycholic Acid

2002